Psychotherapy, pharmacotherapy, and their combination in the treatment of major depressive disorder: How well are we making use of available therapies?

1 World Health Organization. Depression and other common mental disorders: Global Health Estimates. 2017. Available at: https://apps.who.int/iris/handle/10665/254610 Search in Google Scholar

2 Greenberg PE, Fournier A-A, Sisitsky T, Simes M, Berman R, Koenigsberg SH, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). PharmacoEconomics. 2021;39(6):653-665. Search in Google Scholar

3 Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, et al. The Lancet Commission on Global Mental Health and Sustainable Development. Lancet. 2018;392(10157):1553–1598. Search in Google Scholar

4 Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, et al. Undertreatment of people with major depressive disorder in 21 countries. BJPsych. 2017;210(2):119-124. Search in Google Scholar

5 World Health Organization. Suicide. 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/suicide Search in Google Scholar

6 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 2013. Search in Google Scholar

7 Paykel ES. Basic concepts of depression. Dialogues Clin Neurosci. 2008;10(3):279–289. Search in Google Scholar

8 Blackburn TP. Depressive disorders: Treatment failures and poor prognosis over the last 50 years. Pharmacol Res Perspect. 2019;7(3). Search in Google Scholar

9 Penner-Goeke S, Binder EB. Epigenetics and depression. Dialogues Clin Neurosci. 2019;21(4):397-405 Search in Google Scholar

10 Garcia-Toro M, Aguirre I. Biopsychosocial model in Depression revisited. Med Hypotheses. 2007;68(3): 683–691. Search in Google Scholar

11 Cohen ZD, DeRubeis RJ. Treatment selection in depression. Annu Rev Clin Psychol. 2018;14(1):209-236. Search in Google Scholar

12 Cuijpers P, Quero S, Noma H, Ciharova M, Miguel C, Karyotaki E, et al. Psychotherapies for depression: A network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 2021;20(2):283-293. Search in Google Scholar

13 Al-Harbi KS. Treatment-resistant depression: Therapeutic trends, challenges, and Future Directions. Patient Prefer Adherence. 2012;6:369-388. Search in Google Scholar

14 aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. CMAJ. 2009;180(3):305–313. Search in Google Scholar

15 Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New Perspectives for Refining Future Treatment Approaches. Lancet Psychiatry. 2017;4(5):409–418. Search in Google Scholar

16 Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J. Neurobiology of depression: An integrated view of key findings. Int J Clin Pract. 2007;61(12):2030–2040. Search in Google Scholar

17 Boku S, Nakagawa S, Toda H, Hishimoto A. Neural basis of major depressive disorder: Beyond monoamine hypothesis. PCN. 2017;72(1):3–12. Search in Google Scholar

18 Villas Boas GR, Boerngen de Lacerda R, Paes MM, Gubert P, Almeida WL, Rescia VC, et al. Molecular aspects of depression: A review from neurobiology to treatment. Eur J Pharmacol. 2019;851:99–121. Search in Google Scholar

19 Castrén E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry. 2021;90(2):128–136. Search in Google Scholar

20 Cole J, Costafreda SG, McGuffin P, Fu CHY. Hippocampal atrophy in first episode depression: A meta-analysis of Magnetic Resonance Imaging Studies. J Affect Disord. 2011;134(1–3):483–487. Search in Google Scholar

21 Lang UE, Borgwardt S. Molecular mechanisms of depression: Perspectives on New Treatment Strategies. Cell Physiol Biochem. 2013;31(6):761–777. Search in Google Scholar

22 Su KP. Inflammation in psychopathology of depression: Clinical, biological, and therapeutic implications. BioMedicine. 2012;2(2):68–74. Search in Google Scholar

23 Makhija K, Karunakaran S. The role of inflammatory cytokines on the aetiopathogenesis of depression. Aust N Z J Psychiatry. 2013;47(9):828–839. Search in Google Scholar

24 Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815. Search in Google Scholar

25 McGuffin P, Katz R, Bebbington P. Hazard, heredity and depression. A family study. J. Psychiatr. Res. 1987; 21: 365-375. Search in Google Scholar

26 Peña CJ, Nestler EJ. Progress in epigenetics of depression. Prog Mol Biol Transl Sci. 2018;157:41–66. Search in Google Scholar

27 Park C, Rosenblat JD, Brietzke E, Pan Z, Lee Y, Cao B, et al. Stress, epigenetics and depression: A systematic review. Neurosci Biobehav Rev. 2019;102:139–152. Search in Google Scholar

28 Fenn K, Byrne M. The key principles of cognitive behavioural therapy. InnovAiT. 2013;6(9):579–585. Search in Google Scholar

29 D’Zurilla TJ, Nezu AM, Problem-solving therapy, in Dobson KS (ed): Handbook of Cognitive-behavioral Therapies, Guilford Press, NY, 2010, 197–225. Search in Google Scholar

30 Markowitz JC, Weissman MM. Interpersonal psychotherapy: principles and applications. World Psychiatry. 2004;3(3):136-139. Search in Google Scholar

31 Summers RF, Barber JP. Psychodynamic therapy: A guide to evidence-based practice. Guilford Press, NY, 2010. Search in Google Scholar

32 Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006;74(4):658–670. Search in Google Scholar

33 Stahl SM, Grady MM, Muntner N. Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications, Cambridge University Press, Cambridge, UK, 2021. Search in Google Scholar

34 Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: From monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23(1):1–21. Search in Google Scholar

35 Lopez-Munoz F, Alamo C. Monoaminergic neurotransmission: The history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15(14):1563–1586. Search in Google Scholar

36 Berton O, Nestler EJ. New approaches to antidepressant drug discovery: Beyond monoamines. Nat Rev Neurosci. 2006;7(2):137–151. Search in Google Scholar

37 Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New Perspectives for Refining Future Treatment Approaches. Lancet Psychiatry. 2017;4(5):409–418. Search in Google Scholar

38 Wang Q, Dwivedi Y. Advances in novel molecular targets for antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110041. Search in Google Scholar

39 Jarończyk M, Walory J. Novel molecular targets of antidepressants. Molecules. 2022;27(2):533. Search in Google Scholar

40 Weissman MM, Prusoff BA, Dimascio A, Neu C, Goklaney M, Klerman GL. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry. 1979;136(4B):555-558. Search in Google Scholar

41 Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342(20):1462-1470. Search in Google Scholar

42 de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord. 2001;64(2-3):217-229. Search in Google Scholar

43 DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):409-416. Search in Google Scholar

44 Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006;74(4):658-670. Search in Google Scholar

45 Segal ZV, Bieling P, Young T, et al. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry. 2010;67(12):1256-1264. Search in Google Scholar

46 Nakagawa A, Mitsuda D, Sado M, et al. Effectiveness of Supplementary Cognitive-Behavioral Therapy for Pharmacotherapy-Resistant Depression: A Randomized Controlled Trial. J Clin Psychiatry. 2017;78(8):1126-1135. Search in Google Scholar

47 Quigley L, Dozois DJA, Bagby RM, Lobo DSS, Ravindran L, Quilty LC. Cognitive change in cognitive-behavioural therapy v. pharmacotherapy for adult depression: a longitudinal mediation analysis. Psychol Med. 2019;49(15):2626-2634. Search in Google Scholar

48 Hemanny C, Carvalho C, Maia N, et al. Efficacy of trial-based cognitive therapy, behavioral activation and treatment as usual in the treatment of major depressive disorder: preliminary findings from a randomized clinical trial. CNS Spectr. 2020;25(4):535-544. Search in Google Scholar

49 Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909-922. Search in Google Scholar

50 Imel ZE, Malterer MB, McKay KM, Wampold BE. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord. 2008;110(3):197-206. Search in Google Scholar

51 Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58(7):376-385. Search in Google Scholar

52 Leichsenring F, Steinert C, Hoyer J. Psychotherapy Versus Pharmacotherapy of Depression: What’s the Evidence?. Z Psychosom Med Psychother. 2016;62(2):190-195. Search in Google Scholar

53 Karyotaki E, Smit Y, Holdt Henningsen K, et al. Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. J Affect Disord. 2016;194:144-152. Search in Google Scholar

54 Kamenov K, Twomey C, Cabello M, Prina AM, Ayuso-Mateos JL. The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis. Psychol Med. 2017;47(3):414-425. Search in Google Scholar

55 Hofmann SG, Curtiss J, Carpenter JK, Kind S. Effect of treatments for depression on quality of life: a meta-analysis. Cogn Behav Ther. 2017;46(4):265-286. Search in Google Scholar

56 Kappelmann N, Rein M, Fietz J, et al. Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry. BMC Med. 2020;18(1):170. Search in Google Scholar

57 Cuijpers P, Noma H, Karyotaki E, Vinkers CH, Cipriani A, Furukawa TA. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020;19(1):92-107. Search in Google Scholar

58 Breedvelt JJF, Warren FC, Segal Z, Kuyken W, Bockting CL. Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis. JAMA Psychiatry. 2021;78(8):868-875. Search in Google Scholar

59 Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-2321. Search in Google Scholar

60 Katon W, Guico-Pabia CJ. Improving quality of depression care using organized systems of care: a review of the literature. Prim Care Companion CNS Disord. 2011;13(1):PCC.10r01019blu. Search in Google Scholar

61 Ormel J, Kessler RC, Schoevers R. Depression: more treatment but no drop in prevalence: how effective is treatment? And can we do better?. Curr Opin Psychiatry. 2019;32(4):348-354. Search in Google Scholar